Although strides have been made with regards to understanding the roles of EP3 and EP4 in the regulation of cardiac contractility, the extent to which EP3 or EP4 modulation alters cardiomyocyte contractility or cardiac function in the setting of hyperglycemia or T2D remains unexplored. Here, PTGER4 is linked to type 2 diabetes mellitus.